Development Level

Tbio 10 | 10,625
Tchem 3 | 1,890
Tclin 3 | 602
Tdark 3 | 7,003

IMPC Term

abnormal seminal vesicle morph... 1 | 47
decreased KLRG1+ CD4 alpha bet... 1 | 2
decreased body weight 1 | 174
decreased circulating amylase ... 1 | 24
decreased circulating free fat... 1 | 39
decreased circulating serum al... 1 | 79
decreased circulating triglyce... 1 | 83
decreased leukocyte cell numbe... 1 | 54
decreased lumbar vertebrae num... 1 | 62
enlarged heart 1 | 111
increased circulating alkaline... 1 | 119
increased sacral vertebrae num... 1 | 62
mydriasis 1 | 9
preweaning lethality, incomple... 1 | 260
vertebral transformation 1 | 12

Disease

Fibrinogen Adverse Event 19 | 20
osteosarcoma 11 | 7,933
Atherosclerosis 9 | 275
glioblastoma 9 | 5,572
lung cancer 9 | 4,466
ovarian cancer 9 | 8,484
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,956
medulloblastoma, large-cell 8 | 6,234
pilocytic astrocytoma 8 | 3,086
Carcinoma 7 | 2,147
Rheumatoid Arthritis 7 | 1,160
Breast cancer 6 | 3,094
juvenile dermatomyositis 6 | 1,189
non-small cell lung cancer 6 | 2,798
oligodendroglioma 6 | 2,849
acute quadriplegic myopathy 5 | 1,157
astrocytic glioma 5 | 2,241
atypical teratoid / rhabdoid tumor 5 | 4,369
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,988
invasive ductal carcinoma 5 | 2,950
lung carcinoma 5 | 2,844
pancreatic cancer 5 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,795
pediatric high grade glioma 5 | 2,712
psoriasis 5 | 6,685
subependymal giant cell astrocytoma 5 | 2,287
tuberculosis 5 | 1,557
ulcerative colitis 5 | 2,087
Pick disease 4 | 1,893
cystic fibrosis 4 | 1,665
ependymoma 4 | 2,514
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
pituitary cancer 4 | 1,972
primitive neuroectodermal tumor 4 | 3,031
Alzheimer's disease 3 | 644
Arthritis 3 | 248
Asthma 3 | 349
Cancer 3 | 2,346
Juvenile rheumatoid arthritis 3 | 104
Osteoporosis 3 | 257
adrenocortical carcinoma 3 | 1,427
group 3 medulloblastoma 3 | 2,254
interstitial cystitis 3 | 2,299
malignant mesothelioma 3 | 3,162
posterior fossa group A ependymoma 3 | 1,511
Acquired metabolic disease 2 | 267
Afibrinogenemia 2 | 4
Amyloidosis 2 | 68
Autistic Disorder 2 | 320
Congenital afibrinogenemia 2 | 9
Congenital hypofibrinogenemia 2 | 3
Coronary artery disease 2 | 240
Crohn Disease 2 | 97
Crohn's disease 2 | 304
Duchenne muscular dystrophy 2 | 602
Dysfibrinogenemia, Congenital 2 | 3
IGA Glomerulonephritis 2 | 454
Inflammatory Bowel Diseases 2 | 87
Inflammatory bowel disease 2 | 142
Kidney disease 2 | 396
Pneumonia 2 | 133
Schizophrenia 2 | 501
Systemic primary carnitine deficiency disease 2 | 16
Thrombophilia 2 | 36
active Crohn's disease 2 | 918
acute myeloid leukemia 2 | 780
atypical teratoid/rhabdoid tumor 2 | 1,095
cutaneous lupus erythematosus 2 | 1,056
dermatomyositis 2 | 933
diabetes mellitus 2 | 1,663
gastric cancer 2 | 430
lung adenocarcinoma 2 | 2,713
mucosa-associated lymphoid tissue lymphoma 2 | 480
nasopharyngeal carcinoma 2 | 1,056
pancreatic carcinoma 2 | 567
posterior fossa group B ependymoma 2 | 1,530
primary Sjogren syndrome 2 | 789
primary pancreatic ductal adenocarcinoma 2 | 1,271
sonic hedgehog group medulloblastoma 2 | 1,482
Adverse reaction to drug 1 | 54
Ankylosing spondylitis 1 | 138
Bipolar Disorder 1 | 266
Brachydactyly 1 | 52
Chronic Lymphocytic Leukemia 1 | 242
Dermatologic disorders 1 | 65
Drug allergy 1 | 36
Drug-Induced Liver Injury 1 | 118
Exanthem 1 | 39
Gaucher disease type 1 1 | 171
Hemolytic anemia 1 | 66
Kidney Diseases 1 | 86
Liver Cirrhosis, Experimental 1 | 108
Meningitis 1 | 46
Mevalonic aciduria 1 | 12
Parkinson Disease 1 | 102
Pulmonary Embolism 1 | 45
Sensorineural hearing loss 1 | 107
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
interstitial lung disease 1 | 291
permanent atrial fibrillation 1 | 44

Tissue

Blood and immune system 19 | 17,995
Cardiovascular System 19 | 17,958
Digestive Tract 19 | 18,473
Endocrine System 19 | 18,512
Female tissues 19 | 18,647
Liver and Pancreas 19 | 18,136
Male tissues 19 | 17,969
Nervous System 19 | 18,561
Respiratory system 19 | 17,484
Skin and soft tissues 19 | 18,115
Urinary Tract 19 | 18,444

Target Family

Non-IDG 12 | 11,971
Enzyme 4 | 4,146
Epigenetic 2 | 242
Transporter 1 | 473

GWAS Trait

Fibrinogen 19 | 19
Obesity-related traits 380 | 380
Schizophrenia 334 | 334
Height 250 | 250
Post bronchodilator FEV1/FVC r... 192 | 192
Body mass index 180 | 180
IgG glycosylation 162 | 162
Inflammatory bowel disease 117 | 117
Post bronchodilator FEV1 112 | 112
Crohn's disease 110 | 110
Blood metabolite levels 103 | 103
Type 2 diabetes 94 | 94
3-hydroxy-1-methylpropylmercap... 93 | 93
3-hydroxypropylmercapturic aci... 92 | 92
Ulcerative colitis 89 | 89
Platelet count 79 | 79
Systemic lupus erythematosus 78 | 78
HDL cholesterol 76 | 76
Rheumatoid arthritis 74 | 74
Cholesterol, total 73 | 73
Menarche (age at onset) 73 | 73
Diisocyanate-induced asthma 72 | 72
Multiple sclerosis 68 | 68
LDL cholesterol 67 | 67
QT interval 58 | 58
Metabolite levels 55 | 55
Atopic dermatitis 54 | 54
Bipolar disorder and schizophr... 54 | 54
Breast cancer 54 | 54
Prostate cancer 54 | 54
Triglycerides 53 | 53
Bipolar disorder 52 | 52
HIV-1 control 50 | 50
Post bronchodilator FEV1/FVC r... 50 | 50
HIV-1 viral setpoint 49 | 49
Cognitive performance 48 | 48
Amyotrophic lateral sclerosis ... 46 | 46
Bone mineral density 46 | 46
Clozapine-induced agranulocyto... 46 | 46
Attention deficit hyperactivit... 44 | 44
Blood pressure 44 | 44
Coronary heart disease 43 | 43
Glomerular filtration rate (cr... 43 | 43
Parkinson's disease 43 | 43
Type 1 diabetes 42 | 42
PR interval in Tripanosoma cru... 40 | 40
Post bronchodilator FEV1 in CO... 39 | 39
Alzheimer's disease (cognitive... 38 | 38
Educational attainment 38 | 38
Pulmonary function 38 | 38
Diffuse large B cell lymphoma 37 | 37
Inflammatory skin disease 37 | 37
Beta-2 microglubulin plasma le... 36 | 36
Glucose homeostasis traits 36 | 36
Urate levels 36 | 36
Blood metabolite ratios 35 | 35
Psoriasis 35 | 35
Autism spectrum disorder, atte... 34 | 34
Migraine 33 | 33
Coronary artery disease 32 | 32
Metabolic traits 32 | 32
Waist-to-hip ratio adjusted fo... 32 | 32
Cognitive function 31 | 31
Colorectal cancer 31 | 31
Amyotrophic lateral sclerosis 30 | 30
Myopia (pathological) 30 | 30
Obesity 30 | 30
Response to amphetamines 30 | 30
Systolic blood pressure 30 | 30
Alzheimer's disease (late onse... 29 | 29
Celiac disease 29 | 29
Phospholipid levels (plasma) 29 | 29
Red blood cell traits 29 | 29
Advanced age-related macular d... 28 | 28
Dental caries 28 | 28
Fibrinogen levels 28 | 28
Parental extreme longevity (95... 28 | 28
Pulmonary function (interactio... 28 | 28
Asthma 27 | 27
Cognitive decline rate in late... 27 | 27
Glomerular filtration rate in ... 27 | 27
Longevity 27 | 27
Mean platelet volume 27 | 27
Chronic kidney disease 26 | 26
Diabetic kidney disease 26 | 26
Diastolic blood pressure 26 | 26
Coronary artery calcification 25 | 25
Metabolic syndrome 25 | 25
Pancreatic cancer 25 | 25
Protein quantitative trait loc... 25 | 25
Hypertension 24 | 24
Migraine - clinic-based 24 | 24
Parental longevity (combined p... 24 | 24
Primary biliary cirrhosis 24 | 24
Thiazide-induced adverse metab... 24 | 24
Menopause (age at onset) 23 | 23
Response to antipsychotic trea... 23 | 23
Age-related macular degenerati... 22 | 22
Immune response to smallpox va... 22 | 22
Mild influenza (H1N1) infectio... 22 | 22
Sudden cardiac arrest 22 | 22

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fibrinogen alpha chain FGA Tbio Non-IDG -2.84597 716.2 457
Interleukin-1 receptor type 1 IL1R1 Tclin Non-IDG -2.63413 362.9 482
Solute carrier family 22 member 4 SLC22A4 Tchem Transporter -3.04092 1151.9 69
Fibrinogen beta chain FGB Tbio Non-IDG -2.04286 111.3 330
Chromodomain-helicase-DNA-binding protein 9 CHD9 Tbio Epigenetic -0.55978 5.89 24
NACHT, LRR and PYD domains-containing protein 3 NLRP3 Tchem Non-IDG -3.18465 1655.7 459
FERM, RhoGEF and pleckstrin domain-containing protein 2 FARP2 Tbio Non-IDG -0.77619 6.73 83
Ras-related protein Rab-37 RAB37 Tbio Enzyme -0.87034 8.11 124
Protocadherin-23 DCHS2 Tdark Non-IDG -0.44734 2.79 2
Membrane-spanning 4-domains subfamily A member 6A MS4A6A Tbio Non-IDG -0.79958 7.43 98